Document is current
Any future updates will be listed below
-
Authors
El Ghalbouni, A. https://orcid.org/0009-0009-0639-5756
Snijders, T. J.
Tolboom, N.
Braat, A. J. A. T.
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (KWF Kankerbestrijding)
- License Information
-
More Information
Article History
Received: 4 November 2025
Accepted: 20 December 2025
First Online: 14 January 2026
Declarations
:
: The patient provided informed consent for the publication of their case details.
: Nelleke Tolboom is consultant for Telix Pharmaceuticals and Theranova and receives in kind research support from Curium Pharmaceuticals. Arthur Braat is consultant for Boston Scientific, Terumo, GE Healthcare & Telix Pharmaceuticals, receives research support from Boston Scientific, Telix Pharmaceuticals, Ariceum Therapeutics & Siemens Healthineers. All others authors have no relevant financial or non-financial interests to disclose.
